TickerFacts.

Quest Diagnostics Inc (DGX): Gross Profit

Revenue minus cost of revenue for the same annual period and currency, computed by TickerFacts from the filed figures. The issuer may report gross profit or margin on a different basis.

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2010-12-31, 2011-12-31, 2016-12-31, 2017-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$3.67B
Year ended 2025-12-31
$3.83B
Trailing 12 months to 2026-06-30
+2.2%
3-year compound annual growth
+0.2%
5-year compound annual growth
$4.21B2007-12-31: $2.74B2008-12-31: $2.99B2009-12-31: $3.13B2010-12-31: $2.98B2011-12-31: $3.03B2012-12-31: $3.02B2013-12-31: $2.82B2014-12-31: $2.80B2015-12-31: $2.84B2016-12-31: $2.60B2017-12-31: $2.68B2018-12-31: $2.60B2019-12-31: $2.69B2020-12-31: $3.63B2021-12-31: $4.21B2022-12-31: $3.43B2023-12-31: $3.05B2024-12-31: $3.24B2025-12-31: $3.67B$3.67B
2007-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$3.67B+13.0%2026-02-26, From 2025-01-01
2024-12-31$3.24B+6.3%2026-02-26, From 2024-01-01
2023-12-31$3.05B-11.1%2026-02-26, From 2023-01-01
2022-12-31$3.43B-18.4%2025-02-20, From 2022-01-01
2021-12-31$4.21B+15.9%2024-02-22, From 2021-01-01
2020-12-31$3.63B+35.1%2023-02-21, From 2020-01-01
2019-12-31$2.69B+3.2%2022-02-28, From 2019-01-01
2018-12-31$2.60B-2.9%2021-02-22, From 2018-01-01
2017-12-31$2.68Bn/c2020-02-20, From 2017-01-01
2016-12-31$2.60Bn/c2019-02-21, From 2016-01-01
2015-12-31$2.84B+1.4%2018-02-23, From 2015-01-01
2014-12-31$2.80B-0.8%2017-02-22, From 2014-01-01
2013-12-31$2.82B-6.6%2016-02-26, From 2013-01-01
2012-12-31$3.02B-0.4%2015-02-24, From 2012-01-01
2011-12-31$3.03Bn/c2014-02-18, From 2011-01-01
2010-12-31$2.98Bn/c2013-02-27, From 2010-01-01
2009-12-31$3.13B+4.7%2012-02-16, From 2009-01-01
2008-12-31$2.99B+9.4%2011-02-16, From 2008-01-01
2007-12-31$2.74Bn/a2010-02-17, From 2007-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Quest Diagnostics Inc (DGX)2025-12-31$3.67B+13.0%
Labcorp Holdings Inc. (LH)2025-12-31$4.01B+10.7%
Guardant Health, Inc. (GH)2025-12-31$633.01M+40.9%
Veracyte, Inc. (VCYT)2025-12-31$362.53M+21.6%
Castle Biosciences Inc (CSTL)2025-12-31$273.20M+0.5%
Fulgent Genetics, Inc. (FLGT)2025-12-31$130.88M+22.1%
BillionToOne, Inc. (BLLN)2025-12-31$208.46M+157.6%
Personalis, Inc. (PSNL)2025-12-31$15.78M-41.2%
Exagen Inc. (XGN)2025-12-31$38.80M+17.2%

Compare DGX, LH, GH, VCYT side by side · Screen every company in Services-Medical Laboratories ↗